Previous studies have shown that downregulation of cav-1 in breast cancer has led to cancer invasion and metastasis [10, 11, 47], poor clinical outcome [48], altered therapy responses [49], and decreased progression-free survival time [10, 11]. The gene discussed is CAV1; the disease is cancer.